Radiotherapy and toll-like receptor agonists.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Seminars in Radiation Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.semradonc.2014.07.006PMID 25481264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

  2014cited by this paper
• Intratumoral Immunization: A New Paradigm for Cancer Therapy

  2014cited by this paper
• Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.

  2014cited by this paper
• Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma.

  2013cited by this paper
• Bacillus Calmette‐Guérin immunotherapy for genitourinary cancer

  2013cited by this paper
• An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non–Small Cell Lung Cancer

  2013cited by this paper
• Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.

  2013cited by this paper
• Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.

  2013cited by this paper
• BCG immunotherapy for bladder cancer—the effects of substrain differences

  2013cited by this paper
• The abscopal effect associated with a systemic anti-melanoma immune response.

  2013cited by this paper
• Immunogenic cell death in cancer therapy.

  2013cited by this paper
• Intratumoral Anti-CTLA-4 Therapy: Enhancing Efficacy While Avoiding Toxicity

  2013cited by this paper
• Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

  2012cited by this paper
• Trial Watch

  2012cited by this paper
• Targeting pattern recognition receptors in cancer immunotherapy

  2012cited by this paper
• Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma.

  2012cited by this paper
• Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

  2012cited by this paper
• Immunologic correlates of the abscopal effect in a patient with melanoma.

  2012cited by this paper
• Abscopal effect in a patient with melanoma.

  2012cited by this paper
• The secret ally: immunostimulation by anticancer drugs

  2012cited by this paper
• In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.

  2012cited by this paper
• A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

  2012cited by this paper
• Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas

  2011cited by this paper
• Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

  2011cited by this paper
• A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation

  2011cited by this paper
• γ-Radiation Promotes Immunological Recognition of Cancer Cells through Increased Expression of Cancer-Testis Antigens In Vitro and In Vivo

  2011cited by this paper
• The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity.

  2011cited by this paper
• Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy.

  2010cited by this paper
• Radiation-induced cell death mechanisms

  2010cited by this paper
• Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.

  2010cited by this paper
• In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study.

  2010cited by this paper
• Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.

  2009cited by this paper
• Radiation induces an antitumour immune response to mouse melanoma

  2009cited by this paper
• Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody

  2009cited by this paper
• Radiation-induced bystander signalling in cancer therapy

  2009cited by this paper
• Systemic effects of local radiotherapy.

  2009cited by this paper
• Invariant Natural Killer T Cells Regulate Breast Cancer Response to Radiation and CTLA-4 Blockade

  2009cited by this paper
• Molecular characteristics of immunogenic cancer cell death

  2008cited by this paper
• Calreticulin exposure dictates the immunogenicity of cancer cell death

  2007cited by this paper
• The TLR4 polymorphism predicts the response of breast cancer patients to anthracyclins

  2007cited by this paper
• The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

  2007cited by this paper
• Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

  2007cited by this paper
• Imiquimod: mode of action

  2007cited by this paper
• Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

  2006cited by this paper
• Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.

  2005cited by this paper
• Combination of Conformal Radiotherapy and Intratumoral Injection of Adoptive Dendritic Cell Immunotherapy in Refractory Hepatoma

  2005cited by this paper
• Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

  2005cited by this paper
• Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor1

  2005cited by this paper
• Combining radiotherapy and immunotherapy: a revived partnership.

  2005cited by this paper
• New insights on cell death from radiation exposure.

  2005cited by this paper
• Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.

  2005cited by this paper
• Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis

  2005cited by this paper
• Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity

  2004cited by this paper
• Recognition of single-stranded RNA viruses by Toll-like receptor 7.

  2004cited by this paper
• Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8

  2004cited by this paper
• External Beam Radiation of Tumors Alters Phenotype of Tumor Cells to Render Them Susceptible to Vaccine-Mediated T-Cell Killing

  2004cited by this paper
• Ligand-regulated Chimeric Receptor Approach Reveals Distinctive Subcellular Localization and Signaling Properties of the Toll-like Receptors*

  2004cited by this paper
• CpG Oligodeoxynucleotide Enhances Tumor Response to Radiation

  2004cited by this paper
• Ionizing Radiation Affects Human MART-1 Melanoma Antigen Processing and Presentation by Dendritic Cells1

  2004cited by this paper
• Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway

  2003cited by this paper
• Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways

  2003cited by this paper
• Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 41

  2002cited by this paper
• Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication.

  2002cited by this paper
• Novel Signal Transduction Pathway Utilized by Extracellular HSP70

  2002cited by this paper
• Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

  2002cited by this paper
• Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1

  2001cited by this paper
• Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

  2001cited by this paper
• HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine

  2000cited by this paper
• Irradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells.

  2000cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2000cited by this paper
• Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells1

  2000cited by this paper
• Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer.

  1999cited by this paper
• Unresponsiveness of MyD88-deficient mice to endotoxin.

  1999cited by this paper
• Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

  1998cited by this paper
• A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

  1997cited by this paper
• The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults.

  1996cited by this paper
• Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium.

  1996cited by this paper
• The product of the tobacco mosaic virus resistance gene N: similarity to toll and the interleukin-1 receptor.

  1994cited by this paper
• Coley's toxins

  1992cited by this paper
• Drosophila Toll and IL-1 receptor

  1991cited by this paper
• The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein.

  1988cited by this paper
• A. Chekhov, M.D., and Coley's toxins.

  1987cited by this paper
• The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research.

  1946cited by this paper
• Contribution To The Knowledge Of Sarcoma

  1891cited by this paper
• II. Contribution to the Knowledge of Sarcoma.

  year unknowncited by this paper

• Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus-Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial.

  2026cites this paper
• Design, synthesis, biological evaluation and in silico studies of novel quinoline derivatives as potential radioprotective molecules targeting the TLR2 and p53 pathways.

  2024cites this paper
• Novel Combination Treatment for Melanoma: FLASH Radiotherapy and Immunotherapy Delivered by a Radiopaque and Radiation Responsive Hydrogel.

  2023cites this paper
• Targeting Tumor Physical Microenvironment for Improved Radiotherapy

  2022cites this paper
• Cell repopulation, rewiring metabolism, and immune regulation in cancer radiotherapy

  2020cites this paper
• Intratumoral Immunotherapy: From Trial Design to Clinical Practice

  2020cites this paper
• Pure abscopal effect of radiotherapy in a salivary gland carcinoma: Case report, literature review, and a search for new approaches.

  2020cites this paper
• Radiation induces changes in toll-like receptors of the uterine cervix of the rat

  2019cites this paper
• Prognostic value of post-radiotherapy neutrophil-to-lymphocyte ratio in locally advanced nasopharyngeal carcinoma

  2019cites this paper
• A Chinese herbal prescription Yiqi Jiedu decoction attenuates irradiation induced testis injury in mice.

  2019cites this paper
• Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment

  2019cites this paper
• Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell–Mediated Inflammation and Immunosuppression

  2019cites this paper
• Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.

  2018cites this paper
• Biomolecular markers in head and neck cancer

  2017cites this paper
• Immunomodulation by ionizing radiation—impact for design of radio‐immunotherapies and for treatment of inflammatory diseases

  2017cites this paper
• Intratumoral immunotherapy: using the tumor as the remedy

  2017cites this paper
• Recent Advancements in Pancreatic Cancer Immunotherapy

  2016cites this paper
• Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF

  2016cites this paper
• Radiation takes its Toll.

  2015cites this paper
• Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?

  2015cites this paper
• The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

  2015cites this paper
• Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives.

  2015cites this paper
• The potential complementary role of targeted alpha therapy in the management of metastatic melanoma.

  2015cites this paper